Building Better Vaccines: Iaso Therapeutics

Vaccines have dominated the news. With the COVID-19 pandemic, stories about vaccines have been a daily occurrence. They range from concerns about safety to vaccination rates and distribution. They highlight the amazing science that led to the commercial development of novel technologies. The public has probably heard more about vaccines in recent days than they can remember. With the public’s attention, these news stories also highlight the benefit of new vaccines and can show the need for new, safe, and effective vaccine technologies to prepare us for the next disease threat and to protect us against known diseases that are challenging to treat.